BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1449037)

  • 1. Cytologic and immunocytochemical studies of cerebrospinal fluid in meningeal sarcoidosis. A case report.
    Li CY; Yam LT
    Acta Cytol; 1992; 36(6):963-7. PubMed ID: 1449037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurosarcoidosis: correlation of cerebrospinal fluid findings with diffuse leptomeningeal gadolinium enhancement on MRI and clinical disease activity.
    Wengert O; Rothenfusser-Korber E; Vollrath B; Bohner G; Scheibe F; Otto C; Hofmann J; Angstwurm K; Ruprecht K
    J Neurol Sci; 2013 Dec; 335(1-2):124-30. PubMed ID: 24071064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic pitfalls in cerebrospinal fluid cytology.
    Takeda M; King DE; Choi HY; Gomi K; Lang WR
    Acta Cytol; 1981; 25(3):245-50. PubMed ID: 6942615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of T lymphocytes in human blood and cerebrospinal fluid with Helix pomatia A hemagglutinin.
    Schädlich HJ; Bliersbach Y; Weidenhammer J
    Acta Cytol; 1984; 28(4):411-3. PubMed ID: 6331702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic analysis of cerebrospinal fluid cells over the course of Lyme meningoradiculitis.
    Sindern E; Malin JP
    Acta Cytol; 1995; 39(1):73-5. PubMed ID: 7847012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cerebrospinal fluid CD4/CD8 ratio and interleukin-6 and -10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study.
    Chazal T; Costopoulos M; Maillart E; Fleury C; Psimaras D; Legendre P; Pineton de Chambrun M; Haroche J; Lubetzki C; Amoura Z; Legarff-Tavernier M; Cohen Aubart F
    Eur J Neurol; 2019 Oct; 26(10):1274-1280. PubMed ID: 31021023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reassessment of cytologic values in canine cerebrospinal fluid by use of cytocentrifugation.
    Christopher MM; Perman V; Hardy RM
    J Am Vet Med Assoc; 1988 Jun; 192(12):1726-9. PubMed ID: 3410789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immunoregulatory mechanisms in the central nervous system: characterization of noninflammatory and inflammatory cerebrospinal fluid lymphocytes.
    Matsui M; Mori KJ; Saida T
    Ann Neurol; 1990 Jun; 27(6):647-51. PubMed ID: 2360801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytodiagnosis in the cerebrospinal fluid with special reference to illness course phases in diseases of the central nervous system].
    Olischer RM
    Psychiatr Neurol Med Psychol (Leipz); 1988 Oct; 40(10):609-16. PubMed ID: 3237867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central nervous system sarcoidosis.
    Khoury J; Wellik KE; Demaerschalk BM; Wingerchuk DM
    Neurologist; 2009 Mar; 15(2):108-11. PubMed ID: 19276791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of interferon-gamma and IL-6 producing cells in cerebrospinal fluid cells in the central nervous system infectious diseases using immunocytochemistry].
    Nakamura S; Nagano I; Yoshioka M; Onodera J; Kogure K
    Rinsho Shinkeigaku; 1992 Feb; 32(2):143-7. PubMed ID: 1611772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid cytology in histiocytic proliferative disorders.
    Hamilton SR; Gupta PK; Marshall ME; Donovan PA; Wingard JR; Zaatari GS
    Acta Cytol; 1982; 26(1):22-8. PubMed ID: 6175126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurosarcoidosis: cerebrospinal fluid lymphocyte subpopulations.
    Stern BJ; Griffin DE; Luke RA; Krumholz A; Johns CJ
    Neurology; 1987 May; 37(5):878-81. PubMed ID: 2952900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of elevated levels of soluble factors in the cerebrospinal fluid in patients with adult T-cell leukemia.
    Uozumi K; Ishitsuka K; Ohno N; Nakahara K; Utsunomiya A; Hanada S; Arima T
    Leuk Lymphoma; 1995 Nov; 19(5-6):437-45. PubMed ID: 8590844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric analysis of cerebrospinal fluid samples and its usefulness in routine clinical practice.
    Subirá D; Castañón S; Aceituno E; Hernández J; Jiménez-Garófano C; Jiménez A; Jiménez AM; Román A; Orfao A
    Am J Clin Pathol; 2002 Jun; 117(6):952-8. PubMed ID: 12047148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the cerebrospinal fluid in leukemic meningosis].
    Wieczorek V; Zintl F; Stahl J; Aurich G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(4):357-65. PubMed ID: 4107569
    [No Abstract]   [Full Text] [Related]  

  • 17. [The cerebrospinal fluid and neurocysticercosis: evolutional aspects of the cellular inflammatory response].
    Machado LR
    Arq Neuropsiquiatr; 1987 Dec; 45(4):353-63. PubMed ID: 3449020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytologic features of cerebrospinal fluid in Lyme disease.
    Razavi-Encha F; Fleury-Feith J; Gherardi R; Bernaudin JF
    Acta Cytol; 1987; 31(4):439-40. PubMed ID: 3604539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport and production of cerebrospinal fluid (CSF) change in aging humans under normal and diseased conditions.
    Kleine TO; Hackler R; Lütcke A; Dauch W; Zöfel P
    Z Gerontol; 1993; 26(4):251-5. PubMed ID: 8212795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The absence of CD56 on malignant plasma cells in the cerebrospinal fluid is the hallmark of multiple myeloma involving central nervous system.
    Chang H; Bartlett ES; Patterson B; Chen CI; Yi QL
    Br J Haematol; 2005 May; 129(4):539-41. PubMed ID: 15877737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.